Journal of Angiotherapy
Angiogenesis, Inflammation & Therapeutics | Online ISSN  2207-872X
  1. You are here:
  2. Home
  3. Journals
  4. Biological Sciences
RESEARCH ARTICLE   (Open Access)
Contents Vol 8 (4)

Differential Expression of Annexin A1 Protein in Colorectal, Lung, and Liver Cancer Tissues

Hind Younis Khalaf 1, Nagam Khudhair 2*, Baydaa Abdul Sattar Atiyha 3

+ Author Affiliations

Journal of Angiotherapy 8 (4) 1-5 https://doi.org/10.25163/angiotherapy.849549

Submitted: 31 January 2024 Revised: 03 April 2024  Published: 07 April 2024 

Abstract

Background: Annexin A1 (ANXA1) is a phospholipid-binding protein involved in mediating the anti-inflammatory effects of glucocorticoids. Its role in inflammation regulation and its association with various diseases, including cancer, have been extensively studied. ANXA1 is expressed in multiple tissues and plays a crucial role in cell growth, differentiation, and apoptosis regulation. Dysregulation of ANXA1 expression has been observed in several cancer types, highlighting its potential as a diagnostic and prognostic marker. Methods: This study aimed to evaluate the expression of ANXA1 in colorectal, lung, and liver cancer tissues using immunohistochemical analysis. Tissue samples were obtained from 29 newly diagnosed cancer patients undergoing tumor removal. Immunohistochemical staining was performed using ANXA1 antibody, and the staining protocol followed established procedures. Results and Discussion: Immunohistochemical analysis revealed a significant overexpression of ANXA1 in colorectal, lung, and liver cancer tissues compared to standard diagnostic markers. In colorectal cancer, ANXA1 showed higher efficiency in diagnosis than CK20, while in lung cancer, it exhibited higher expression compared to CK7. Previous studies have also linked elevated ANXA1 expression with tumor aggressiveness and poor prognosis in various cancers, including lung and liver cancer. These findings suggest the potential of ANXA1 as a diagnostic marker and prognostic indicator in cancer. Conclusion: ANXA1 antibody staining can serve as a valuable tool for immunohistological diagnosis, indicating tumor spread. Furthermore, the differential expression of ANXA1 across different cancer types underscores its potential utility in cancer diagnosis and prognosis. The observed higher expression of ANXA1 in lung cancer tissues compared to liver and colon cancer tissues highlights its significance in specific cancer types.

Keywords: Annexin A1, cancer, Immunohistochemistry, Tumor markers, Diagnostic tool

References

Alldridge LC, Bryant CE.(2003). Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Exp Cell Res. 290(1):93–107.

Bai XF, Ni XG, Zhao P, et al.(2004). Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J Gastroenterol. 10(10):1466–1470. doi:10.3748/wjg.v10. i10.1466.

Cheng SX, Tu Y, Zhang S.(2013). FoxM1 promotes glioma cells progression by up-regulating Anxa1 expression. PLoS One.8(8): e72376. doi:10.1371/journal.pone.0072376.

Clark GB, Morgan RO, Fernandez MP, Roux SJ.(2012). Evolutionary adaptation of plant annexins has diversified their molecular structures, interactions and functional roles. New Phytol. 196 (3):695–712. doi:10.1111/j.1469-8137.2012.04308.x.

D‘Acunto CW, Gbelcova H, Festa M, Ruml T. The complex understanding of Annexin A1 phosphorylation. Cell Signal. 2014;26 (1):173–178. doi:10.1016/j.cellsig.2013.09.020.

Gerke V, Moss SE. (2002). Annexins: from structure to function. Physiol       Rev. 82(2):331–371. doi:10.1152/physrev.00030.2001.

Hai-Tao Luo , Cai-Xia Liang , Rong-Cheng Luo and Wei-Guang Gu.(2017). Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer. Bioscience Reports ; 37 BSR20171086 https://doi.org/10.1042/BSR20171086.

Han G, Tian Y, Duan B, Sheng H, Gao H, Huang J.(2014). Association of nuclear Annexin A1 with prognosis of patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol. 7 (2):751–759.

Jorge YC, Mataruco MM, Araujo LP, et al.(2013). Expression of annexin-A1 and galectin-1 anti-inflammatory proteins and mRNA in chronic gastritis and gastric cancer. Mediators Inflamm. 2013:152860. doi:10.1155/2013/152860

Lin Y, Lin G, Fang W, Zhu H and Chu K.(2014). Increased expression of annexin A1 predicts poor prognosis in human hepatocellular carcinoma and enhances cell malignant phenotype. Med Oncol 31: 327.

Liu YF, Zhang PF, Li MY, Li QQ, Chen ZC.(2011). Identification of Annexin A1 as a proinvasive and prognostic factor for lung adenocarcinoma. Clin Exp Metastasis. 28(5):413–425. doi:10.1007/s10585-011-9380-1.

Min-Chun Chuang, Jr-Hau Lung, Yi-Chuan Chen, Yu-Ching Lin, Ya-Chin Li, Ming-Szu Hung (2021). The Association of Annexin A1 and Chemosensitivity to Osimertinib in Lung Cancer Cells. 15;13(16):4106. doi: 10.3390/cancers13164106.

Patton KT, Chen HM, Joseph L, Yang XJ.(2005). Decreased annexin I expression in prostatic adenocarcinoma and in high-grade prostatic intraepithelial neoplasia. Histopathology. 47 (6):597–601. doi:10.1111/j.1365-2559.2005.02300.x 98.

Perretti M, Solito E.(2004). Annexin 1 and neutrophil apoptosis. Biochem Soc Trans. 32(Pt3):507–510. doi:10.1042/BST0320507.

Rong B., Zhao C., Liu H.et al.(2014). Elevated serum annexin A1 as potential diagnostic marker for lung cancer: a retrospective case-control study. Am J Transl Res.  6(5): 558–569.

Seaton BA, Dedman JR.(1998). Annexins. BioMetals. 11(4):399–404.

Silistino-Souza R, Rodrigues-Lisoni FC, Cury PM, et al. (2007).Annexin 1: differential expression in tumor and mast cells in human larynx cancer. Int J Cancer. 120(12):2582–2589. doi:10.1002/ijc.22639

Su N, Xu XY, Chen H, et al.(2010). Increased expression of Annexin A1 is correlated with K-ras mutation in colorectal cancer. Tohoku J Exp Med. 222(4):243–250.

Suo A, Zhang M, Yao Y, Zhang L, Huang C, Nan K and Zhang W.(2021).Proteome analysis of the effects of sorafenib on human hepatocellular carcinoma cell line HepG2. Med Oncol 29: 1827-1836.

Wang LD, Yang YH, Liu Y, Song HT, Zhang LY, Li PL.(2008). Decreased expression of Annexin A1 during the progression of cervical neoplasia. J Int Med Res. 36(4):665–672. doi:10.1177/ 147323000803600407.

Williams SL, Milne IR, Bagley CJ, et al.(2010). A proinflammatory role for proteolytically cleaved Annexin A1 in neutrophil transendothelial migration. J Immunol. 185(5):3057–3063. doi:10.4049/ jimmunol.1000119.

Xi Wang ,Gang Shao ,Xiangyu Hong ,Yue Shi ,Yiting Zheng,Yucheng Yu      andCaiyun Fu.(2023).Targeting Annexin A1 as a Druggable Player to Enhance the Anti-Tumor Role of Honokiol in Colon Cancer through Autophagic Pathway. Pharmaceuticals , 16(1), 70; https://doi.org/10.3390/ph16010070.

PDF
Abstract
Export Citation

View Dimensions


View Plumx


View Altmetric




Save
0
Citation
434
View

Share